Bharat Immunolog

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE994B01014
  • NSEID:
  • BSEID: 524663
INR
9.00
0.26 (2.97%)
BSENSE

Nov 20

BSE+NSE Vol: 20.45 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 936506,
    "name": "Bharat Immunolog",
    "stock_name": "Bharat Immunolog",
    "full_name": "Bharat Immunological & Biological Corporation Ltd",
    "name_url": "stocks-analysis/bharat-immunolog",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "9.00",
    "chg": 0.26,
    "chgp": "2.97%",
    "dir": 1,
    "prev_price": "8.74",
    "mcapval": "40.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524663,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE994B01014",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "20.45 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/bharat-immunolog-936506-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-4235159",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BharatImmunolog_mojoScore_4235159.png",
        "date": "2026-10-23 10:10:33",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 April 2024. However, the analysis and financial metrics discussed below reflect the company’s current position as of 23 October 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 9.05 as Sell-Off Deepens",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bharat-immunological-biological-corporation-ltd-hits-52-week-low-amid-continued-downtrend-4209499",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BharatImmunolog_priceRelatedfactors_4209499.png",
        "date": "2026-09-30 09:47:08",
        "description": "For the sixth consecutive session, Bharat Immunological & Biological Corporation Ltd has closed lower, culminating in a fresh 52-week low of Rs 9.05 on 30 Sep 2026. This marks a steep 33.79% decline over this losing streak, underscoring persistent selling pressure despite a modestly recovering Sensex."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-4208438",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BharatImmunolog_mojoScore_4208438.png",
        "date": "2026-09-29 10:10:40",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 Apr 2024. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 29 September 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 12.85 as Sell-Off Deepens",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bharat-immunological-biological-corporation-ltd-hits-52-week-low-amidst-continued-downtrend-4205047",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BharatImmunolog_priceRelatedfactors_4205047.png",
        "date": "2026-09-25 11:06:53",
        "description": ""
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 13.02 as Sell-Off Deepens",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bharat-immunological-biological-corporation-ltd-hits-52-week-low-amidst-continued-downtrend-4203270",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BharatImmunolog_priceRelatedfactors_4203270.png",
        "date": "2026-09-24 09:48:34",
        "description": "A sharp decline has pushed Bharat Immunological & Biological Corporation Ltd to a fresh 52-week low of Rs 13.02 on 24 Sep 2026, marking a continuation of recent losses amid a challenging market environment and company-specific headwinds."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 13.3 as Sell-Off Deepens",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bharat-immunological-biological-corporation-ltd-falls-to-52-week-low-of-rs133-4202645",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BharatImmunolog_priceRelatedfactors_4202645.png",
        "date": "2026-09-23 13:06:03",
        "description": "For the fifth consecutive session, Bharat Immunological & Biological Corporation Ltd closed lower, slipping to a fresh 52-week low of Rs 13.3 on 23 Sep 2026, marking a 38.17% decline over the past year amid persistent underperformance and deteriorating fundamentals."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 13.96 as Sell-Off Deepens",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bharat-immunological-biological-corporation-ltd-falls-to-52-week-low-of-rs1396-4200027",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BharatImmunolog_priceRelatedfactors_4200027.png",
        "date": "2026-09-21 13:06:50",
        "description": "For the third consecutive session, Bharat Immunological & Biological Corporation Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 13.96 on 21 Sep 2026. This marks a significant 38.2% drop from its 52-week high of Rs 22.61, underscoring persistent selling pressure despite a broadly positive market backdrop."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 14.06 as Sell-Off Deepens",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bharat-immunological-biological-corporation-ltd-hits-52-week-low-amidst-continued-downtrend-4197290",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BharatImmunolog_priceRelatedfactors_4197290.png",
        "date": "2026-09-18 10:13:06",
        "description": "A sharp decline in Bharat Immunological & Biological Corporation Ltd shares has pushed the stock to a fresh 52-week low of Rs 14.06 on 18 Sep 2026, marking a 7.21% drop over the past two sessions amid continued underperformance relative to its sector and benchmark indices."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-4196209",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BharatImmunolog_mojoScore_4196209.png",
        "date": "2026-09-17 10:10:56",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 09 April 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 September 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      }
    ],
    "total": 30,
    "sid": "936506",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/bharat-immunological-biological-corporation-936506"
  },
  "announcements": [
    {
      "caption": "Clarification sought from Bharat Immunologicals & Biologicals Corporation Ltd",
      "datetime": "30-Sep-2026",
      "details": "The Exchange has sought clarification from Bharat Immunologicals & Biologicals Corporation Ltd on September 30 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Winding-up",
      "datetime": "17-Sep-2026",
      "details": "Pursuant to the Regulation 30 and other applicable Regulation(s) of SEBI LODR It is informed that the Government of India has approved the closure of Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) under Administrative control of Department of Biotechnology Ministry of Science & Technology Government of India. This information is being submitted with reference to the communication received on 17.09.2026 from Department of Biotechnology.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBIS LODR.",
      "datetime": "07-Aug-2024",
      "details": "BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 16th August 2024 for General Purpose.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Clarification sought from Bharat Immunologicals & Biologicals Corporation Ltd

30-Sep-2026 | Source : BSE

The Exchange has sought clarification from Bharat Immunologicals & Biologicals Corporation Ltd on September 30 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.

The reply is awaited.

Announcement under Regulation 30 (LODR)-Winding-up

17-Sep-2026 | Source : BSE

Pursuant to the Regulation 30 and other applicable Regulation(s) of SEBI LODR It is informed that the Government of India has approved the closure of Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) under Administrative control of Department of Biotechnology Ministry of Science & Technology Government of India. This information is being submitted with reference to the communication received on 17.09.2026 from Department of Biotechnology.

Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBIS LODR.

07-Aug-2024 | Source : BSE

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 16th August 2024 for General Purpose.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available